
Glimepiride (4mg)
Active composition
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Glimisave 4 Tablet contains Glimepiride 4 mg, an oral hypoglycemic agent belonging to the sulfonylurea class, indicated for the management of type 2 diabetes mellitus. Glimepiride acts by stimulating pancreatic beta cells to release insulin, thereby improving glycemic control in patients with non-insulin-dependent diabetes. It is primarily prescribed when diet, exercise, and weight reduction alone are insufficient to achieve adequate blood glucose levels. Glimepiride enhances insulin secretion in a glucose-dependent manner, reducing the risk of hypoglycemia compared to older sulfonylureas. The medication is typically administered once daily with breakfast or the first main meal to optimize absorption and efficacy. Clinical use requires monitoring of blood glucose levels and periodic assessment of renal and hepatic function to adjust dosage accordingly and minimize adverse effects. Common side effects include hypoglycemia, gastrointestinal disturbances, and allergic skin reactions. Caution is advised in patients with hepatic or renal impairment, and it should be used with care in elderly patients. Glimisave 4 Tablet should not be used in type 1 diabetes, diabetic ketoacidosis, or during pregnancy and lactation unless clearly indicated. Patient education on lifestyle modification and adherence to therapy is essential for optimal outcomes.
How to use Glimisave Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimisave 4 Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glimisave 4 Tablet.
High Risk
Glimisave 4 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glimisave 4 Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimisave 4 Tablet may be needed. Please consult your doctor. However, the use of Glimisave 4 Tablet is not recommended in patients with severe liver disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
Glimisave 4 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with Glimisave 4 Tablet
Consult Doctor
Glimisave 4 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glimisave 4 Tablet may be needed. Please consult your doctor. Use of Glimisave 4 Tablet is not recommended in patients with severe kidney disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
0 reviews for Glimisave 4 Tablet

Glimepiride (4mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Glimisave 4 Tablet contains Glimepiride 4 mg, an oral hypoglycemic agent belonging to the sulfonylurea class, indicated for the management of type 2 diabetes mellitus. Glimepiride acts by stimulating pancreatic beta cells to release insulin, thereby improving glycemic control in patients with non-insulin-dependent diabetes. It is primarily prescribed when diet, exercise, and weight reduction alone are insufficient to achieve adequate blood glucose levels. Glimepiride enhances insulin secretion in a glucose-dependent manner, reducing the risk of hypoglycemia compared to older sulfonylureas. The medication is typically administered once daily with breakfast or the first main meal to optimize absorption and efficacy. Clinical use requires monitoring of blood glucose levels and periodic assessment of renal and hepatic function to adjust dosage accordingly and minimize adverse effects. Common side effects include hypoglycemia, gastrointestinal disturbances, and allergic skin reactions. Caution is advised in patients with hepatic or renal impairment, and it should be used with care in elderly patients. Glimisave 4 Tablet should not be used in type 1 diabetes, diabetic ketoacidosis, or during pregnancy and lactation unless clearly indicated. Patient education on lifestyle modification and adherence to therapy is essential for optimal outcomes.
How to use Glimisave Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimisave 4 Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glimisave 4 Tablet.
High Risk
Glimisave 4 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glimisave 4 Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimisave 4 Tablet may be needed. Please consult your doctor. However, the use of Glimisave 4 Tablet is not recommended in patients with severe liver disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
Glimisave 4 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with Glimisave 4 Tablet
Consult Doctor
Glimisave 4 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glimisave 4 Tablet may be needed. Please consult your doctor. Use of Glimisave 4 Tablet is not recommended in patients with severe kidney disease. These patients can experience very low blood sugar levels which may become normal after a long time.
Regular Checkup
0 reviews for Glimisave 4 Tablet













